Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis
Jianzhen Ye,1 Guangrui Deng,1 Feng Gao2 1Department of Endocrinology, Huangzhou District People’s Hospital, Huanggang, People’s Republic of China; 2Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People&a...
Main Authors: | Ye J, Deng G, Gao F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/theoretical-overview-of-clinical-and-pharmacological-aspects-of-the-us-peer-reviewed-article-DDDT |
Similar Items
-
Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
by: Shigematsu T, et al.
Published: (2018-09-01) -
Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
by: Friedl C, et al.
Published: (2018-06-01) -
Three Patients with Lithium-Associated Hyperparathyroidism: Literature Review Regarding Medical and Surgical Management
by: Ramy M. Hanna, et al.
Published: (2019-08-01) -
A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro
by: Lilit V. Egshatyan
Published: (2020-06-01) -
A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism
by: Keitaro Yokoyama, et al.
Published: (2017-07-01)